デフォルト表紙
市場調査レポート
商品コード
1006233

経肺ドラッグデリバリー装置の世界市場:製品タイプ別、アプリケーション別、流通チャネル別の予測(2026年まで)- COVID-19の累積的影響

Pulmonary Drug Delivery Devices Market Research Report by Product Type, by Application, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
経肺ドラッグデリバリー装置の世界市場:製品タイプ別、アプリケーション別、流通チャネル別の予測(2026年まで)- COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のドラッグデリバリー装置の市場規模は、2020年の425億2,937万米ドルから2025年末までに539億8,668万米ドルに拡大すると予想されています。

COVID-19は、ほぼすべての業界に影響を与えた未曾有の世界の公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されています。当レポートでは、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げ消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19の影響について考察しています。

当レポートは、世界の経肺ドラッグデリバリー装置市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の累積的影響、製品タイプ・アプリケーション・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • ステークホルダー

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査設計
    • 準備:調査器具
    • 収集:データソース
    • 分析:データ解釈
    • 策定:データ検証
    • 発行:調査報告書
    • 繰り返し:レポートの更新
  • 調査実施
    • 開始:調査プロセス
    • 計画:調査計画の策定
    • 実行:調査の実施
    • 検証:発見と分析
    • 発行:調査報告書
  • 調査の成果

第3章 エグゼクティブサマリー

  • 市場展望
  • 製品タイプ別市場の展望
  • アプリケーション別市場の展望
  • 流通チャネル別市場の展望
  • 地域別市場の展望
  • 競合他社の見通し

第4章 市場概要

  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターのファイブフォース分析

第6章 製品タイプ別市場

  • ドライパウダー吸入器
  • 計量吸入器
  • ネブライザー

第7章 アプリケーション別市場

  • 喘息
  • COPD
  • 嚢胞性線維症

第8章 流通チャネル別市場

  • 病院薬局
  • 小売薬局

第9章 南北アメリカ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域市場

  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカ市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、パートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第13章 企業プロファイル

  • 3M Healthcare
  • AstraZeneca Plc
  • Boehringer Ingelheim Gmbh
  • GF Health Products, Inc.
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.
  • Novartis AG
  • Omron Corporation
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格
  • 連絡先の詳細
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2026
  • FIGURE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2026 (USD BILLION)
  • FIGURE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2026 (USD BILLION)
  • FIGURE 16. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 17. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 18. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 20. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, 2018-2026 (USD BILLION)
  • FIGURE 25. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
  • FIGURE 27. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
  • FIGURE 29. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 34. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 36. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 37. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 38. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 39. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 40. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 41. CALIFORNIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 42. FLORIDA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 43. ILLINOIS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 44. NEW YORK PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 45. OHIO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. PENNSYLVANIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. TEXAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 49. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 51. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 60. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 62. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 74. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 75. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. CALIFORNIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. CALIFORNIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. CALIFORNIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. FLORIDA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. FLORIDA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. FLORIDA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. ILLINOIS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. ILLINOIS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. ILLINOIS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. NEW YORK PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. NEW YORK PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. NEW YORK PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. OHIO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. OHIO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. OHIO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. PENNSYLVANIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. PENNSYLVANIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. PENNSYLVANIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. TEXAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. TEXAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. TEXAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: SCORES
  • TABLE 121. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: BUSINESS STRATEGY
  • TABLE 122. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: PRODUCT SATISFACTION
  • TABLE 123. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: RANKING
  • TABLE 124. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 125. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: SHARE, BY COMPANY, 2020
  • TABLE 126. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: MERGER & ACQUISITION
  • TABLE 127. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 128. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 129. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: INVESTMENT & FUNDING
  • TABLE 130. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 131. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: LICENSE & PRICING
  • TABLE 132. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: CONTACT DETAILS
目次
Product Code: MRR-035AB9C0DA4B

The Global Pulmonary Drug Delivery Devices Market size was estimated at USD 42.52 Billion in 2020 and expected to reach USD 44.82 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 5.72% to reach USD 59.39 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Pulmonary Drug Delivery Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product Type, the Pulmonary Drug Delivery Devices Market was studied across Dry Powder Inhaler, Metered Dose Inhaler, and Nebulizer.

Based on Application, the Pulmonary Drug Delivery Devices Market was studied across Asthma, COPD, and Cystic Fibrosis.

Based on Distribution Channel, the Pulmonary Drug Delivery Devices Market was studied across Hospital Pharmacies and Retail Pharmacy Stores.

Based on Geography, the Pulmonary Drug Delivery Devices Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pulmonary Drug Delivery Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pulmonary Drug Delivery Devices Market, including Actelion, Actelion, Aerogen, AstraZeneca Plc, Boehringer Ingelheim Gmbh, Briggs Healthcare, Inc., Celares GmbH, Cipla Inc, GF Health Products, Inc., Gilbert Technologies, GlaxoSmithKline Plc, Jabil Inc, Koninklijke Philips N.V., MannKind Corporation, Merck & Co., Inc., Mylan N.V., Novartis AG, Omron Corporation, Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, and The 3M Company.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Pulmonary Drug Delivery Devices Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pulmonary Drug Delivery Devices Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pulmonary Drug Delivery Devices Market?
  • 4. What is the competitive strategic window for opportunities in the Global Pulmonary Drug Delivery Devices Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Pulmonary Drug Delivery Devices Market?
  • 6. What is the market share of the leading vendors in the Global Pulmonary Drug Delivery Devices Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Pulmonary Drug Delivery Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Type Outlook
  • 3.4. Application Outlook
  • 3.5. Distribution Channel Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of chronic respiratory diseases globally
      • 5.1.1.2. Surge in use of development of digital or smart inhalers
      • 5.1.1.3. Increasing shift toward pulmonary drug delivery devices as alternate route
    • 5.1.2. Restraints
      • 5.1.2.1. Issues concerned with price and regulations
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technological advancements in pulmonary devices
      • 5.1.3.2. Increasing healthcare expenditure on therapeutic devices
    • 5.1.4. Challenges
      • 5.1.4.1. Difficulty in maintenance due to deposition of aerosolized particles
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Pulmonary Drug Delivery Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Dry Powder Inhaler
  • 6.3. Metered Dose Inhaler
  • 6.4. Nebulizer

7. Pulmonary Drug Delivery Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. COPD
  • 7.4. Cystic Fibrosis

8. Pulmonary Drug Delivery Devices Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Retail Pharmacy Stores

9. Americas Pulmonary Drug Delivery Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Pulmonary Drug Delivery Devices Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Pulmonary Drug Delivery Devices Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Actelion
  • 13.2. Actelion
  • 13.3. Aerogen
  • 13.4. AstraZeneca Plc
  • 13.5. Boehringer Ingelheim Gmbh
  • 13.6. Briggs Healthcare, Inc.
  • 13.7. Celares GmbH
  • 13.8. Cipla Inc
  • 13.9. GF Health Products, Inc.
  • 13.10. Gilbert Technologies
  • 13.11. GlaxoSmithKline Plc
  • 13.12. Jabil Inc
  • 13.13. Koninklijke Philips N.V.
  • 13.14. MannKind Corporation
  • 13.15. Merck & Co., Inc.
  • 13.16. Mylan N.V.
  • 13.17. Novartis AG
  • 13.18. Omron Corporation
  • 13.19. Sunovion Pharmaceuticals Inc.
  • 13.20. Teva Pharmaceutical Industries Ltd
  • 13.21. Teva Pharmaceutical Industries Ltd
  • 13.22. The 3M Company

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details